Search
for
Sort by
Research 31–60 of 1000+
- Cardiac and Renal SARS-CoV-2 Viral Entry Protein Regulation by Androgens and Diet: Implications for Polycystic Ovary Syndrome and COVID-19
- Proteolysis‐Targeting Chimera (PROTAC): Current Applications and Future Directions
- Use of Antiandrogens as Therapeutic Agents in COVID-19 Patients
- Androgen sensitivity gateway to COVID‐19 disease severity
- Constitutive Internalization of the Leucine-rich G Protein-coupled Receptor-5 (LGR5) to the Trans-Golgi Network
- PROTACs: A novel strategy for cancer drug discovery and development
- Protein degradation: expanding the toolbox to restrain cancer drug resistance
- Calreticulin: non‐endoplasmic reticulum functions in physiology and disease
- Androgen deprivation therapy may constitute a more effective COVID-19 prophylactic than therapeutic strategy
- Is COVID-19 Gender-sensitive?
- Late unexpected consequences of COVID‐19 infection in survivors of acute hypoxic respiratory failure
- Androgens in SARS-CoV-2 Coronavirus Infections
- A preliminary observation: Male pattern hair loss among hospitalized COVID‐19 patients in Spain – A potential clue to the role of androgens in COVID‐19 severity
- An Assessment on Impact of COVID-19 Infection in a Gender Specific Manner
- Repurposing existing drugs for COVID-19: an endocrinology perspective
- Testosterone target therapy: focus on immune response, controversies and clinical implications in patients with COVID-19 infection
- TMPRSS2: A Key Host Factor in SARS-CoV-2 Infection and Potential Therapeutic Target
- Comment on “Androgens and women: COVID‐19 outcomes in women with acne vulgaris, polycystic ovarian syndrome, and hirsutism”
- Sexual dimorphism of COVID-19 inspires drug repositioning and host-targeting immunotherapy for viral pneumonia
- Hair Loss and Androgen’s Role in the Era of COVID-19
- Editor’s picks January 2021
- Testosterone in COVID-19 – Foe, Friend or Fatal Victim?
- Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies
- COVID-19: Understanding Inter-Individual Variability and Implications for Precision Medicine
- Androgenetic alopecia in COVID-19: Compared to age-matched epidemiologic studies and hospital outcomes with or without the Gabrin sign
- Alopecia and grey hair are associated with COVID‐19 Severity
- COVID‐19, androgens, and androgenic alopecia
- Effects of 5‐alpha reductase inhibitors on lung function: A reason for discontinuation duringCOVID‐19 pandemic?
- Recommendations on trichological treatments during COVID-19 pandemic
- Androgenetic alopecia in women and men is not related to COVID‐19 infection severity: a prospective cohort study of hospitalized COVID‐19 patients